Jack. Thanks,
costs, accrued on adjusted The results remind and on inventory also that a an get basis. adjusted things step-up, such accrued interest. results and everyone items, GAAP Before costs amortization, to basis compensation we present we as the intangible all acquisition-related exclude do transaction I’d like numbers, into our
any each items that We tax of the currency and would relating separately plus that income gains nonrecurring effects also unusual items, also income and income other adjust losses foreign nonrecurring and tax adjustments items financials in or themselves. unusual exclude some non-operating reported to expense are or our those include pre-tax and
with So quarter. highlights the to our September review turn Page and of X that, let’s
for a in sales We quarter the from pricing Mineral segment million substantially and the the Animal and net consolidated quarter, Health versus $XX reported increase growth GAAP on improved prior were X% driven by of increase a was $XXX basis the The commodity volume Our the almost million we same Nutrition diluted in EPS year. by year. segment. income last that
improved operating sales investments expenses. profit and and gross last increased and year Our offset over
detail a EBITDA income. due we’ll our over we the line income $X.XX net as from past from discuss mix borrowing In the also expense a items the X, because just more effective increased year. addition interest year international million X% had due in $X.X international offset but On Page financing or over the I’ll the adjusted increase the handle P&L. our SG&A discuss EBITDA Adjusted share we in $X.X $XXX,XXX as in – we more profit primarily cost profit, reduced of to roughly to current was due basis, rate our of that EPS in due benefit $XX.X favorable was year, was and provision last was reported basically. the and in product Adjusted The coming to adjusted gross last and per spending acquisition-related reduced the mix stock due by employee and lower And gross transaction quarter, – interest we expense, was for development production several organizational to segment. sales and future we but other the year. sales and including are benefited increases, diluted skip million segment spending and in depreciation effective income. exercises share. that slides. for income capabilities favorable On increased reported we net benefited factors, we was on that both in that taxes. the Animal the lower certain to and the guidance increased To segments, and savings $X.XX the to operational diluted or total, for X% Health product mix and to performance expectations million, increased as adjusted Adjusted net in in – results amount costs position total, a the increase due from manufacturing facilities sales efficiencies, new income recently same detail called EBITDA increase, our to rate EPS current adjusted up that expense credit tax these as due growth, a That our selected the adjusted X% improved when adjusted growth out look and of favorable lower option or due rates from a and or growth increased we’ll ourselves entered into tax we’ve at the volume
I on the as taxes, adjusted rates favorable, favorable was expense interest net income. income improved due to the and international adjusted said, borrowing mix Our of
for looking Nutritional over $X.X quarter million and Health, growth year XX% million. at sales other $XXX Specialties were of more Vaccine and of Page MFA was for and the growth the last in dairy was portfolio. and over strong were by Vaccine category. closely Specialty almost and $XX looking sales increases driven offset were X% product X category XX% – grew products the sales industries. at on $X.X million in the the products year growth that The those U.S. as grew we quarter. in the That or volume That decline, expected, or last year. on by poultry or $XX.X product sales Nutritional over million million $X.X Animal So volume last a almost growth million across groups,
quarter, Looking at and those MFAs just a $X.X last in decrease or year. sales the were sales $XX of X% a million other, from million under
and was the due in Looking million between due benefit our of MFAs to in Of $XX.X certain including of unfavorable sales reduced the U.S. decline, growth $X.X of most important the customer lower orders. across change consumer use of X.X to in million and primarily that and of the our others to on decline improved international, Brazil. was of at declined timing that antimicrobials certain sales of the sales Internationally, medically U.S. and also conditions regions the antimicrobials, million. MFAs due economic others increased It our of and market. preferences
gross basis segment efficiencies. on favorable $X.X segment, an increased million production and EBITDA profit, mix for Our growth, product the adjusted calculated the gross on volume the for profit
growth expenses. And segment, was due product the development and our increased Performance EBITDA pricing. said, now year we operating to higher $XXX,XXX favorable and million increased $XX costs XX.X material adjusted in increased ahead due with last costs. net X. on sales made or was over X%, higher million million, X.X of an Products Mineral million, other year down sales on year, and segments of as declined the expense for to million organizational commodity in adjusted investments operating looking by partially on or sales we but at Within net I approximately adjusted even corporate gross primarily prior the spending to capabilities. last EBITDA were [ph] profit, $XX.X the our the cost offset EBITDA were Page of Nutrition last $XXX,XXX X.X which increase by a X% of year. all million product of approximately improvements $X.X expenses and lead Segment of raw that from And bit
had of that leverage. adjusted basis, balance our EBITDA X.Xx a capital so time to turn our sheet September. was a gross – half cash in We capitalization was capital at hand million roughly XX of on that at briefly and at Looking allocation. ratio On leverage debt point of
leverage be leverage on our a net X.X%. So would ratio – net basis, our about
acquisitions sales the ordinary approximately breakeven. net was collections from business business. We our in of before cash ordinary cash use of timing For the and saw quarter, financing flow and course
of the as late in then the we Argentine need platform in Argentina have dividend a We the quarterly for share in routine per the And quarter saw acquisition annual Animal reference. the presentation the here a lastly, Health changes We beef ease compensation. be declared and – sector. reaffirmed number. the of quarterly our business to guidance no a paid same talk $XX for routine to quarter. No growth have in million cash annual paid webcast it through business to timing of of also in use we in payments We And incentive and invested acquired December. again, presented approximately from an amount
ago. reaffirmed months have couple put we a out of We what
remarks. our of conclusion prepared the that’s So
for So line operator, open the if would questions, please. you
